标题
Pneumococcal conjugate vaccine use in adults
作者
关键词
-
出版物
Expert Review of Vaccines
Volume -, Issue -, Pages 1-15
出版商
Informa UK Limited
发表日期
2015-12-14
DOI
10.1586/14760584.2016.1132171
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV-infected individuals naive to pneumococcal vaccination
- (2015) As’ad E. Bhorat et al. AIDS
- Immunogenicity, Safety, and Tolerability of 13-Valent Pneumococcal Conjugate Vaccine Followed by 23-Valent Pneumococcal Polysaccharide Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant Aged ≥2 Years: An Open-Label Study
- (2015) Catherine Cordonnier et al. CLINICAL INFECTIOUS DISEASES
- Redefining risk categories for pneumococcal disease in adults: critical analysis of the evidence
- (2015) Daniel Curcio et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study
- (2015) Pauline A Waight et al. LANCET INFECTIOUS DISEASES
- Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance
- (2015) Matthew R Moore et al. LANCET INFECTIOUS DISEASES
- Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults
- (2015) Marc J.M. Bonten et al. NEW ENGLAND JOURNAL OF MEDICINE
- Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease: Table 1
- (2015) Antoni Torres et al. THORAX
- Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 18–49 years of age, naive to 23-valent pneumococcal polysaccharide vaccine
- (2015) K.A. Bryant et al. VACCINE
- Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
- (2015) Miwako Kobayashi et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Open-Label Trial of Immunogenicity and Safety of a 13-Valent Pneumococcal Conjugate Vaccine in Adults ≥50 Years of Age in Mexico
- (2014) Juan Carlos Tinoco et al. Clinical and Vaccine Immunology
- Early Impact of 13-Valent Pneumococcal Conjugate Vaccine on Community-Acquired Pneumonia in Children
- (2014) F. Angoulvant et al. CLINICAL INFECTIOUS DISEASES
- Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults Previously Vaccinated With Pneumococcal Polysaccharide Vaccine
- (2014) M. J. Glesby et al. JOURNAL OF INFECTIOUS DISEASES
- Changes in Childhood Pneumonia and Infant Mortality Rates Following Introduction of the 13-valent Pneumococcal Conjugate Vaccine in Nicaragua
- (2014) Sylvia Becker-Dreps et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Sinusitis and Pneumonia Hospitalization After Introduction of Pneumococcal Conjugate Vaccine
- (2014) Ann Lindstrand et al. PEDIATRICS
- All-Cause Pneumonia Hospitalizations in Children
- (2014) Anders Berglund et al. PLoS One
- Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine–naïve adults 60–64 years of age
- (2014) Richard N. Greenberg et al. VACCINE
- Estimating the burden of hospitalization for pneumococcal pneumonia in a general population aged 50 years or older and implications for vaccination strategies
- (2014) Emanuele Amodio et al. Human Vaccines & Immunotherapeutics
- Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine when administered to healthy Japanese adults aged ≥50 years
- (2014) Masanari Shiramoto et al. Human Vaccines & Immunotherapeutics
- Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis
- (2014) Lone Simonsen et al. Lancet Respiratory Medicine
- Rates of Pneumococcal Disease in Adults With Chronic Medical Conditions
- (2014) Kimberly M. Shea et al. Open Forum Infectious Diseases
- Comparative Immunogenicity and Efficacy of 13-Valent and 7-Valent Pneumococcal Conjugate Vaccines in Reducing Nasopharyngeal Colonization: A Randomized Double-Blind Trial
- (2013) Ron Dagan et al. CLINICAL INFECTIOUS DISEASES
- Pneumococcal infection in adults: burden of disease
- (2013) J.J.C. Drijkoningen et al. CLINICAL MICROBIOLOGY AND INFECTION
- Distribution of 13-Valent Pneumococcal Conjugate Vaccine Streptococcus pneumoniae Serotypes in US Adults Aged >=50 Years With Community-Acquired Pneumonia
- (2013) R. L. Sherwin et al. JOURNAL OF INFECTIOUS DISEASES
- Acute pneumonia and the cardiovascular system
- (2013) Vicente F Corrales-Medina et al. LANCET
- Early Trends for Invasive Pneumococcal Infections in Children After the Introduction of the 13-valent Pneumococcal Conjugate Vaccine
- (2013) Sheldon L. Kaplan et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Estimating the Burden of Pneumococcal Pneumonia among Adults: A Systematic Review and Meta-Analysis of Diagnostic Techniques
- (2013) Maria A. Said et al. PLoS One
- Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older
- (2013) Lisa A. Jackson et al. VACCINE
- Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
- (2013) Lisa A. Jackson et al. VACCINE
- Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults
- (2013) Lisa A. Jackson et al. VACCINE
- Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway
- (2013) Anneke Steens et al. VACCINE
- Serotype-independent pneumococcal vaccines
- (2012) Eliane Namie Miyaji et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Incidence and Cost of Pneumonia in Medicare Beneficiaries
- (2012) Cindy Parks Thomas et al. CHEST
- Validation of an Immunodiagnostic Assay for Detection of 13 Streptococcus pneumoniae Serotype-Specific Polysaccharides in Human Urine
- (2012) Michael W. Pride et al. Clinical and Vaccine Immunology
- Randomized, Controlled Trial of a 13-Valent Pneumococcal Conjugate Vaccine Administered Concomitantly with an Influenza Vaccine in Healthy Adults
- (2012) Robert W. Frenck et al. Clinical and Vaccine Immunology
- Pneumococcal Conjugate Vaccine for Adults: A New Paradigm
- (2012) P. R. Paradiso CLINICAL INFECTIOUS DISEASES
- Understanding the burden of pneumococcal disease in adults
- (2012) F. Blasi et al. CLINICAL MICROBIOLOGY AND INFECTION
- Experiencing Simulated Aging Improves Knowledge of and Attitudes Toward Aging
- (2012) Chiu-Yen Yu et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Impact of 13-valent Pneumococcal Conjugate Vaccine on Pneumococcal Nasopharyngeal Carriage in Children With Acute Otitis Media
- (2012) Robert Cohen et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia
- (2012) Thomas Bewick et al. THORAX
- Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales
- (2012) Nick J. Andrews et al. VACCINE
- Assessment of functional antibacterial opsonophagocytic antibodies elicited by 13-valent pneumococcal conjugate vaccine administered concomitantly with trivalent influenza vaccine in a randomized clinical trial in adults aged ≥65 years
- (2012) Tino F. Schwarz et al. VACCINE
- Healthcare utilization and cost of pneumococcal disease in the United States
- (2011) Susan S. Huang et al. VACCINE
- A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years
- (2011) T.F. Schwarz et al. VACCINE
- Impact of Pneumococcal Conjugate Vaccination of Infants on Pneumonia and Influenza Hospitalization and Mortality in All Age Groups in the United States
- (2011) L. Simonsen et al. mBio
- A Trial of a 7-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults
- (2010) Neil French et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical and economic burden of pneumococcal disease in older US adults
- (2010) Derek Weycker et al. VACCINE
- Efficacy of pneumococcal vaccination in adults: a meta-analysis
- (2009) A. Huss et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Severity of Pneumococcal Pneumonia Associated With Genomic Bacterial Load
- (2009) Jordi Rello et al. CHEST
- Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults
- (2008) Jennifer C. Nelson et al. VACCINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started